The durable clearance of the T315I BCR-ABL mutated clone in chronic phase chronic myelogenous leukemia patients on omacetaxine allows tyrosine kinase inhibitor rechallenge (Q42844339)
Jump to navigation
Jump to search
scientific article published on October 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | The durable clearance of the T315I BCR-ABL mutated clone in chronic phase chronic myelogenous leukemia patients on omacetaxine allows tyrosine kinase inhibitor rechallenge |
scientific article published on October 2010 |
Statements
1 reference
The durable clearance of the T315I BCR-ABL mutated clone in chronic phase chronic myelogenous leukemia patients on omacetaxine allows tyrosine kinase inhibitor rechallenge (English)
1 reference
Franck E Nicolini
1 reference
Jean-Claude Chomel
1 reference
Lydia Roy
1 reference
Laurence Legros
1 reference
Kaddour Chabane
1 reference
Sophie Ducastelle
1 reference
Emmanuelle Nicolas-Virelizier
1 reference
Mauricette Michallet
1 reference
Isabelle Tigaud
1 reference
Jean-Pierre Magaud
1 reference
Ali Turhan
1 reference
François Guilhot
1 reference
Sandrine Hayette
1 reference
1 October 2010
1 reference
1 reference
10
1 reference
5
1 reference
394-399
1 reference
Identifiers
1 reference
1 reference